Özet
This study was conducted to evaluate the effects of factors such as nutrition, physical activity and quality of life contributing to metabolic health on metabolically healthy and overweight/obese individuals. A total of 87 voluntary women aged between 19 and 50 years, who did not have diabetes, hypertension or dyslipidemia and were not pregnant and in the menopausal period having normal body mass index (18,50-24,99 kg/m2) and overweight/obese (BKİ ≥25 kg/m2) were included in the study. A questionnaire was performed to examine the overall characteristics of the individuals, and the data of the anthropometrical measurements and body composition were obtained. The health-related quality of life of the individuals was evaluated using the Short Form-36 (SF-36) quality of life questionnaire, whereas duration of physical activity and sedentary periods were evaluated using the International Physical Activity Questionnaire (IPAQ). In addition, a 24-hour retrospective food consumption record form was used to evaluate a total of two-day food consumption, one day on weekdays and the other day on weekends. The dietary quality of individuals was assessed using the Healthy Eating Index-2005 (HEI-2005) scale. Based on our study results, 56% of overweight/obese individuals were found to be metabolically healthy. Metabolically healthy (MH) overweight/obese individuals were found to have a higher HEI score than the overweight/obese metabolically unhealthy (MU) participants (p<0.05). There was no significant difference between MH overweight/obese and MH normal weighted individuals’s the scores of total HEI score and HEI components (p>0.05). The waist circumference of MH overweight/obese individuals was found to be lower than MU slightly overweight/obese participants (p<0.05). There was no significant difference for physical function and physical role strength of the SF-36 quality of life components between MH and MU overweight/obese participants (p>0.05). There was no statistically significant difference between the MS normal and MS obese individuals in terms of quality of life components (p>0.05). Although of MH overweight/obese individuals’s physical activity scores were higher, there was no significant difference between in the MH and MU oveweight/obese individuals. The underlying factors in the development of the MS phenotype, which is resistant to the metabolic risk factors of obesity, have been discussed in recent years and it is emphasized that lifestyle factors may be a distinctive factor. Identifying the possible effects of lifestyle factors such as healthy nutrition and active life on the development of the obese phenotype of MS will be useful in the treatment of obesity.
Künye
1. Camhi SM, Crouter SE, Hayman LL, Must A, Lichtenstein AH. Lifestyle behaviors in metabolically healthy and unhealthy overweight and obese women: A preliminary study. PloS one. 2015;10(9):e0138548.
2. Primeau V, Coderre L, Karelis A, Brochu M, Lavoie M, Messier V, et al. Characterizing the profile of obese patients who are metabolically healthy. International journal of obesity. 2011;35(7):971.
3. Türkiye Beslenme ve Sağlık Araştırması (TBSA) 2010 Saha Uygulaması El Kitabı. Ankara: T.C. Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü; 2010.
4. Achilike I, Hazuda HP, Fowler SP, Aung K, Lorenzo C. Predicting Development of the Metabolically Healthy Obese Phenotype. International journal of obesity (2005). 2015;39:228.
5. De Lorenzo A, Soldati L, Sarlo F, Calvani M, Di Lorenzo N, Di Renzo L. New obesity classification criteria as a tool for bariatric surgery indication. World journal of gastroenterology. 2016;22(2):681.
6. Camhi SM, Katzmarzyk PT. Differences in body composition between metabolically healthy obese and metabolically abnormal obese adults. International journal of obesity (2005). 2014;38(8):1142.
7. Hayes L, Pearce MS, Firbank MJ, Walker M, Taylor R, Unwin NC. Do obese but metabolically normal women differ in intra-abdominal fat and physical activity levels from those with the expected metabolic abnormalities? A cross-sectional study. BMC public health. 2010;10(1):723.
8. Camhi SM, Evans EW, Hayman LL, Lichtenstein AH, Must A. Healthy eating index and metabolically healthy obesity in US adolescents and adults. Preventive medicine. 2015;77:23-7.
9. Denis GV, Obin MS. ‘Metabolically healthy obesity’: origins and implications. Molecular aspects of medicine. 2013;34(1):59-70.
10. Wildman RP. Healthy obesity. Current Opinion in Clinical Nutrition & Metabolic Care. 2009;12(4):438-43.
11. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Archives of internal medicine. 2008;168(15):1617-24.
12. Hankinson AL, Daviglus ML, Horn LV, Chan Q, Brown I, Holmes E, et al. Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity. 2013;21(3):637-43.
13. Hinnouho G-M, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A. Metabolically healthy obesity and risk of mortality. Diabetes care. 2013;36(8):2294-300.
77
14. Karelis A, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes & metabolism. 2004;30(6):569-72.
15. Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Reviews in Endocrine and Metabolic Disorders. 2013;14(3):219-27.
16. Jokela M, Hamer M, Singh-Manoux A, Batty D, Kivimäki M. Association of metabolically healthy obesity with depressive symptoms: pooled analysis of eight studies. Molecular psychiatry. 2014;19(8):910.
17. Stefan N, Fritsche A, Häring H-U. Mechanisms explaining the relationship between metabolically healthy obesity and cardiovascular risk. Journal of the American College of Cardiology. 2014;63(24):2748-9.
18. Donini LM, Merola G, Poggiogalle E, Lubrano C, Gnessi L, Mariani S, et al. Disability, Physical Inactivity, and Impaired Health-Related Quality of Life Are Not Different in Metabolically Healthy vs. Unhealthy Obese Subjects. Nutrients. 2016;8(12):759.
19. Bell JA, Kivimaki M, Batty GD, Hamer M. Metabolically healthy obesity: What is the role of sedentary behaviour? Preventive medicine. 2014;62:35-7.
20. Sénéchal M, Wicklow B, Wittmeier K, Hay J, MacIntosh AC, Eskicioglu P, et al. Cardiorespiratory fitness and adiposity in metabolically healthy overweight and obese youth. Pediatrics. 2013;132(1):e85-e92.
21. Yu R, Yau F, Ho SC, Woo J. Associations of cardiorespiratory fitness, physical activity, and obesity with metabolic syndrome in Hong Kong Chinese midlife women. BMC public health. 2013;13(1):614.
22. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? The Journal of Clinical Endocrinology & Metabolism. 2001;86(3):1020-5.
23. Jennings CL, Lambert EV, Collins M, Joffe Y, Levitt NS, Goedecke JH. Determinants of insulin‐resistant phenotypes in normal‐weight and obese Black African women. Obesity. 2008;16(7):1602-9.
24. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: different prevalences using different criteria. European Journal of Clinical Nutrition. 2010;64(10):1043.
25. Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, Fitzgerald AP, et al. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PloS one. 2013;8(10):e76188.
26. Roberson LL, Aneni EC, Maziak W, Agatston A, Feldman T, Rouseff M, et al. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality--a systematic review. BMC public health. 2014;14(1):14.
27. Kimokoti RW, Judd SE, Shikany JM, Newby P. Food intake does not differ between obese women who are metabolically healthy or abnormal. The Journal of nutrition. 2014;144(12):2018-26.
78
28. Després J-P, Cartier A, Côté M, Arsenault BJ. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology. Annals of medicine. 2008;40(7):514-23.
29. Brochu M, Mathieu ME, Karelis AD, Doucet É, Lavoie ME, Garrel D, et al. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study. Obesity. 2008;16(5):1085-93.
30. Yang Y, Herting JR, Choi J. Obesity, metabolic abnormality, and health-related quality of life by gender: a cross-sectional study in Korean adults. Quality of Life Research. 2016;25(6):1537-48.
31. World Healt Organization [Internet]. 2017 [Erişim Tarihi 20 Mayıs 2017]. Erişim adresi: http://www.who.int/features/factfiles/obesity/facts/en/
32. Pekcan G. Beslenme durumunun saptanmasi. Diyet El Kitabi Hatipoglu Yayinevi Ankara. 2008:67-141.
33. Wildman RP. Healthy obesity. Current Opinion in Clinical Nutrition & Metabolic Care. 2009,12(4):438-43.
34. Williams G, Fruhbeck G. Obesity: Science to practice: John Wiley & Sons; 2009.
35. Organization WH. Obesity: preventing and managing the global epidemic: World Health Organization; 2000.
36. Bilgiç P. Sporcu ve Sporcu Olmayan Bireylerin Vücut Kompozisyonu ve Beslenme Durumları ile Serum Leptin Düzeylerinin Değerlendirilmesi [Yüksek lisans tezi]: Hacettepe Üniversitesi; 2003.
37. WHO O. Overweight, 2011.
38. Deurenberg P, Yap M, Van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. International Journal of Obesity & Related Metabolic Disorders. 1998;22(12).
39. Pekcan G. Hastanın beslenme durumunun saptanması. Baysal A, Hatiboğlu Yayınevi Ankara. 2002.
40. Phillips CM. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Annals of the New York Academy of Sciences. 2017;1391(1):85-100.
41. Atar İA. Metabolik sendromlu hastalarda koroner arter hastalığı İle postprandiyal hipertrigliserideminin ilişkisi. 2005.
42. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu C-Y, et al. Abdominal visceral and subcutaneous adipose tissue compartments. Circulation. 2007;116(1):39-48.
43. Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. The American journal of clinical nutrition. 2008;87(5):1212-8.
79
44. Chan D, Watts G, Barrett P, Burke V. Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. Qjm. 2003;96(6):441-7.
45. Caballero B. The global epidemic of obesity: an overview. Epidemiologic reviews. 2007;29(1):1-5.
46. Collaboration NRF. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19· 2 million participants. The Lancet. 2016;387(10026):1377-96.
47. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. Jama. 2006;295(13):1549-55.
48. Hwang L-C, Bai C-H, Sun C-A, Chen C-J. Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pacific journal of clinical nutrition. 2012;21(2):227-33.
49. Karelis AD, Faraj M, Bastard J-P, St-Pierre DH, Brochu M, Prud’homme D, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. The Journal of Clinical Endocrinology & Metabolism. 2005;90(7):4145-50.
50. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Archives of internal medicine. 2008;168(15):1609-16.
51. Müller MJ, Bosy-Westphal A, Heller M. ‘Functional’body composition: differentiating between benign and non-benign obesity. F1000 biology reports. 2009;1.
52. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obesity. 2005;13(6):1116-22.
53. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Current diabetes reviews. 2006;2(4):367-73.
54. Expert Panel on Detection E. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama. 2001;285(19):2486.
55. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—a new world‐wide definition. A consensus statement from the international diabetes federation. Diabetic medicine. 2006;23(5):469-80.
56. Bouchard DR, Langlois M-F, Brochu M, Dionne IJ, Baillargeon J-P. Metabolically healthy obese women and functional capacity. Metabolic syndrome and related disorders. 2011;9(3):225-9.
57. Janiszewski PM, Ross R. Effects of weight loss among metabolically healthy obese men and women. Diabetes care. 2010;33(9):1957-9.
80
58. Lynch LA, O'connell JM, Kwasnik AK, Cawood TJ, O'farrelly C, O'shea DB. Are natural killer cells protecting the metabolically healthy obese patient? Obesity. 2009;17(3):601-5.
59. O'Connell J, Lynch L, Cawood TJ, Kwasnik A, Nolan N, Geoghegan J, et al. The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PloS one. 2010;5(4):e9997.
60. Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes care. 2009;32(12):2297-9.
61. Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa‐Lhoret R. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity. 2010;18(5):911-7.
62. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. The Journal of Clinical Endocrinology & Metabolism. 2006;91(8):2906-12.
63. Doumatey AP, Bentley AR, Zhou J, Huang H, Adeyemo A, Rotimi CN. Paradoxical hyperadiponectinemia is associated with the metabolically healthy obese (MHO) phenotype in African Americans. Journal of endocrinology and metabolism. 2012;2(2):51.
64. Karelis A, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia. 2008;51(9):1752-4.
65. Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes care. 2007;30(8):2145-7.
66. Shin M, Hyun Y, Kim O, Kim J, Jang Y, Lee J. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. International journal of obesity. 2006;30(10):1529.
67. Genelhu VA, Celoria BM, Duarte SFP, Cabello PH, Francischetti EA. Not all obese subjects of multiethnic origin are at similar risk for developing hypertension and type 2 diabetes. European journal of internal medicine. 2009;20(3):289-95.
68. RENZOab L, Bigioni M, Bottini F, GOBBO V, Premrov M, CIANCIae R, et al. Normal weight obese syndrome: role of single nucleotide polymorphism of IL-15Rα and MTHFR 677C→ T genes in the relationship between body composition and resting metabolic rate. European review for medical and pharmacological sciences. 2006;10:235-45.
69. Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821-32.
70. Stienstra R, Stefan N. Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity. Diabetologia. 2013;56(11):2343-6.
81
71. Stienstra R, Tack CJ, Kanneganti T-D, Joosten LA, Netea MG. The inflammasome puts obesity in the danger zone. Cell metabolism. 2012;15(1):10-8.
72. Vandanmagsar B, Youm Y-H, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature medicine. 2011;17(2):179-88.
73. Esser N, L’homme L, De Roover A, Kohnen L, Scheen AJ, Moutschen M, et al. Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia. 2013;56(11):2487-97.
74. Li L, Yin J, Cheng H, Wang Y, Gao S, Li M, et al. Identification of genetic and environmental factors predicting metabolically healthy obesity in children: Data from the BCAMS study. The Journal of Clinical Endocrinology & Metabolism. 2016;101(4):1816-25.
75. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obesity reviews. 2010;11(1):11-8.
76. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine reviews. 2000;21(6):697-738.
77. Mathieu P, Poirier P, Pibarot P, Lemieux I, Després J-P. Visceral obesity. Hypertension. 2009;53(4):577-84.
78. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875.
79. Nguyen-Duy T-B, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. American Journal of Physiology-Endocrinology and Metabolism. 2003;284(6):E1065-E71.
80. Indulekha K, Anjana RM, Surendar J, Mohan V. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clinical biochemistry. 2011;44(4):281-7.
81. Philipsen A, Jørgensen ME, Vistisen D, Sandbaek A, Almdal TP, Christiansen JS, et al. Associations between ultrasound measures of abdominal fat distribution and indices of glucose metabolism in a population at high risk of type 2 diabetes: the ADDITION-PRO study. PloS one. 2015;10(4):e0123062.
82. Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology. 2014;59(2):713-23.
83. Frayn KN. Metabolic regulation: a human perspective: John Wiley & Sons; 2009.
84. Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine. 2002;346(16):1221-31.
82
85. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals. Diabetes care. 2011;34(1):210-5.
86. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype. Diabetes care. 2013;36(8):2388-94.
87. Ärnlöv J, Ingelsson E, Sundström J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010;121(2):230-6.
88. Barbarroja N, López-Pedrera R, Mayas MD, García-Fuentes E, Garrido-Sánchez L, Macias-Gonzalez M, et al. The obese healthy paradox: is inflammation the answer? Biochemical Journal. 2010;430(1):141-9.
89. Cherqaoui R, Kassim TA, Kwagyan J, Freeman C, Nunlee‐Bland G, Ketete M, et al. The metabolically healthy but obese phenotype in African Americans. The Journal of Clinical Hypertension. 2012;14(2):92-6.
90. Dai X-P, Liu Z-Q, Xu L-Y, Gong Z-C, Huang Q, Dong M, et al. Association of plasma epinephrine level with insulin sensitivity in metabolically healthy but obese individuals. Autonomic Neuroscience. 2012;167(1):66-9.
91. Hosseinpanah F, Barzin M, Sheikholeslami F, Azizi F. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). The American journal of cardiology. 2011;107(3):412-6.
92. Kantartzis K, Machann J, Schick F, Rittig K, Machicao F, Fritsche A, et al. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia. 2011;54(4):864-8.
93. Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM, et al. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity. 2010;18(12):2354-61.
94. Krzyżanowska-Świniarska B, Kempa A, Miazgowski T, Pilarska K. Serum acylated ghrelin, adiponectin and leptin levels in normal-weight and obese premenopausal women. Hormone and Metabolic Research. 2007;39(11):835-9.
95. Lee JW, Lee HR, Shim JY, Im JA, Kim SH, Choi H, et al. Viscerally obese women with normal body weight have greater brachial‐ankle pulse wave velocity than nonviscerally obese women with excessive body weight. Clinical endocrinology. 2007;66(4):572-8.
96. Mason C, Katzmarzyk PT, Blair SN. Eligibility for obesity treatment and risk of mortality in men. Obesity. 2005;13(10):1803-9.
97. McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation. 2002;106(23):2908-12.
98. Bik W, Ostrowski J, Baranowska-Bik A, Wolinska-Witort E, Bialkowska M, Martynska L, et al. Adipokines and genetic factors in overweight or obese but metabolically healthy Polish women. Neuro endocrinology letters. 2010;31(4):497-506.
83
99. Khan UI, Wang D, Thurston RC, Sowers M, Sutton-Tyrrell K, Matthews KA, et al. Burden of subclinical cardiovascular disease in “metabolically benign” and “at-risk” overweight and obese women: the Study of Women's Health Across the Nation (SWAN). Atherosclerosis. 2011;217(1):179-86.
100. Manu P, Ionescu-Tirgoviste C, Tsang J, Napolitano BA, Lesser ML, Correll CU. Dysmetabolic signals in “metabolically healthy” obesity. Obesity research & clinical practice. 2012;6(1):e9-e20.
101. Sesti G, Folli F, Perego L, Hribal ML, Pontiroli AE. Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PLoS One. 2011;6(3):e17737.
102. Shea JL, Randell EW, Sun G. The Prevalence of Metabolically Healthy Obese Subjects Defined by BMI and Dual‐Energy X‐Ray Absorptiometry. Obesity. 2011;19(3):624-30.
103. Chang Y, Ryu S, Suh B, Yun K, Kim C, Cho S. Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. International journal of obesity. 2012;36(9):1187.
104. Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. Bmj. 2014;349:g4490.
105. Poelkens F, Eijsvogels TM, Brussee P, Verheggen RJ, Tack CJ, Hopman MT. Physical fitness can partly explain the metabolically healthy obese phenotype in women. Experimental and Clinical Endocrinology & Diabetes. 2014;122(02):87-91.
106. Karelis A, Fontaine J, Rabasa-Lhoret R, Prud'homme D, Doucet E, Blanchard C, et al. Psychosocial profile of the metabolically healthy but obese postmenopausal woman. Diabetes & metabolism. 2006;32(1):90-1.
107. Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Scherstén B, Agardh C-D. Socio‐demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes, Obesity and Metabolism. 2003;5(2):106-12.
108. Feldman PJ, Steptoe A. Psychosocial and socioeconomic factors associated with glycated hemoglobin in nondiabetic middle-aged men and women. Health Psychology. 2003;22(4):398.
109. Ryoo J-H, Park SK, Oh C-M, Choi Y-J, Chung JY, Ham WT, et al. Evaluating the risk of hypertension according to the metabolic health status stratified by degree of obesity. Journal of the American Society of Hypertension. 2017;11(1):20-7. e4.
110. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.
84
111. Organization WH. Waist circumference and waist-hip ratio: Report of a WHO expert consultation, Geneva, 8-11 December 2008. 2011.
112. Merdol T. Standart Yemek Tarifeleri (3. bs.). Ankara: Hatipoğlu Yayınevi. 2003.
113. Rakıcıoğlu N, Acar Tek N, Ayaz A, Pekcan G. Yemek ve besin fotoğraf kataloğu. Hatiboğlu Yayınevi. 2012;1.
114. BeBis EJ. Nutrition Data Base Software. Istanbul; 2004.
115. Saglam M, Arikan H, Savci S, Inal-Ince D, Bosnak-Guclu M, Karabulut E, et al. International physical activity questionnaire: reliability and validity of the Turkish version. Perceptual and motor skills. 2010;111(1):278-84.
116. Koçyiğit H, Aydemir Ö, Fişek G, Ölmez N, Memiş AK. Form-36 (KF-36)’nın Türkçe versiyonunun güvenilirliği ve geçerliliği. Ilaç ve tedavi dergisi. 1999;12(1):102-6.
117. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. New England journal of medicine. 1996;334(13):835-40.
118. Guenther PM, Reedy J, Krebs-Smith SM. Development of the healthy eating index-2005. Journal of the American Dietetic Association. 2008;108(11):1896-901.
119. Ortega FB, Cadenas-Sánchez C, Sui X, Blair SN, Lavie CJ. Role of fitness in the metabolically healthy but obese phenotype: a review and update. Progress in cardiovascular diseases. 2015;58(1):76-86.
120. Rey‐Lopez J, Rezende L, Pastor‐Valero M, Tess B. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obesity reviews. 2014;15(10):781-90.
121. Pataky Z, Bobbioni-Harsch E, Golay A. Open questions about metabolically normal obesity. International journal of obesity. 2010;34(S2):S18.
122. Lee K-Y. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pacific journal of clinical nutrition. 2009;18(2):280-4.
123. Srdić B, Stokić E, Korać A, Ukropina M, Veličković K, Breberina M. Morphological characteristics of abdominal adipose tissue in normal-weight and obese women of different metabolic profiles. Experimental and clinical endocrinology & diabetes. 2010;118(10):713-8.
124. Kabat G, Wu WY, Bea J, Chen C, Qi L, Stefanick M, et al. Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women. International Journal of Obesity. 2016.
125. St-Pierre AC, Cantin B, Mauriège P, Bergeron J, Dagenais GR, Després J-P, et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. Canadian Medical Association Journal. 2005;172(10):1301-5.
126. Pataky Z, Makoundou V, Nilsson P, Gabriel R, Lalic K, Muscelli E, et al. Metabolic normality in overweight and obese subjects. Which parameters? Which risks? International journal of obesity. 2011;35(9):1208.
85
127. Aguilar-Salinas CA, García EG, Robles L, Riano D, Ruiz-Gomez DG, García-Ulloa AC, et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. The Journal of Clinical Endocrinology & Metabolism. 2008;93(10):4075-9.
128. Klöting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, Kern M, et al. Insulin-sensitive obesity. American Journal of Physiology-Endocrinology and Metabolism. 2010;299(3):E506-E15.
129. McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, Lamendola C, et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia. 2007;50(8):1707-15.
130. Blüher M. The distinction of metabolically ‘healthy’from ‘unhealthy’obese individuals. Current opinion in lipidology. 2010;21(1):38-43.
131. Karelis AD, Tousignant B, Nantel J, Proteau-Labelle M, Malita FM, St-Pierre DH, et al. Association of insulin sensitivity and muscle strength in overweight and obese sedentary postmenopausal women. Applied Physiology, Nutrition, and Metabolism. 2007;32(2):297-301.
132. Sesti G, Succurro E, Arturi F, Andreozzi F, Laino I, Perticone M, et al. IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant subjects. Nutrition, Metabolism and Cardiovascular Diseases. 2011;21(12):933-40.
133. Baysal A, Aksoy M, Bozkurt N, Merdol T, Pekcan G, Keçecioğlu S, et al. Diyet el kitabı. Ankara: Hatipoğlu Baskı. 2002:225-53.
134. Beslenme BA. Hatiboğlu yayınları: 8. baskı. Ankara; 1999.
135. Jung CH, Kang YM, Jang JE, Hwang JY, Kim EH, Park JY, et al. Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity. Obesity. 2016;24(6):1373-9.
136. Sung K-C, Cha S-C, Sung J-W, So M-S, Byrne CD. Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis. Nutrition, Metabolism and Cardiovascular Diseases. 2014;24(3):256-62.
137. McMorrow AM, Connaughton RM, Lithander FE, Roche HM. Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: potential impact of dietary fat quality. Proceedings of the Nutrition Society. 2015;74(1):67-82.
138. Park Y, Steck S, Fung T, Zhang J, Hazlett L, Han K, et al. Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes. International Journal of Obesity. 2016;40(10):1541-9.
139. Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Archives of internal medicine. 2003;163(4):427-36.
86
140. Bell LK, Edwards S, Grieger JA. The relationship between dietary patterns and metabolic health in a representative sample of adult Australians. Nutrients. 2015;7(8):6491-505.
141. Chiuve SE, Sampson L, Willett WC. The association between a nutritional quality index and risk of chronic disease. American journal of preventive medicine. 2011;40(5):505-13.
142. McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. The American journal of clinical nutrition. 2002;76(2):390-8.
143. Jacobs DR, Gallaher DD. Whole grain intake and cardiovascular disease: a review. Current atherosclerosis reports. 2004;6(6):415-23.
144. Westerterp-Plantenga MS, Lemmens SG, Westerterp KR. Dietary protein–its role in satiety, energetics, weight loss and health. British journal of nutrition. 2012;108(S2):S105-S12.
145. Bazzano LA, Li TY, Joshipura KJ, Hu FB. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes care. 2008;31(7):1311-7.
146. Kolotkin R, Meter K, Williams G. Quality of life and obesity. Obesity reviews. 2001;2(4):219-29.
147. Cui W, Zack MM, Wethington H. Health-related quality of life and body mass index among US adolescents. Quality of Life Research. 2014;23(7):2139-50.
148. Szabo S. the WHOQOL Group: The World Health Organization Quality of Life (WHOQOL) Assessment Instrument. Quality of Life and Pharmacoeconomics in Clinical Trials.355-62.
149. Camhi SM, Waring ME, Sisson SB, Hayman LL, Must A. Physical activity and screen time in metabolically healthy obese phenotypes in adolescents and adults. Journal of obesity. 2013;2013.
